4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-061293
Chief Legal Officer sold 10,455 shares at $1.88 ($19,654)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazzariello Gina Chief Legal Officer | 2024-05-15 | Sale 10b5-1 | −10,455 | $1.88 | $19,654 | 151,477 | D |
| Open-market sales · 10,455 sh · avg $1.88 · $19,654 | |||||||
Loading xslF345X05/ownership.xml…